Hims & Hers Health Inc. Forecast, price target & analysts
Hims & Hers Health Inc. Target price 2025 - Analyst rating & recommendation
Hims & Hers Health Inc. Classifications & Recommendation:
Hims & Hers Health Inc. Price Target
| Target Price | $44.88 |
| Price | $49.41 |
| Deviation |
9.17%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Hims & Hers Health Inc. 2026 .
The average Hims & Hers Health Inc. target price is $44.88.
This is
9.17%
register free of charge
$89.25
80.63%
register free of charge
$28.28
42.76%
register free of charge
|
|
| A rating was issued by 20 analysts: 10 Analysts recommend Hims & Hers Health Inc. to buy, 8 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hims & Hers Health Inc. stock has an average upside potential 2026 of
9.17%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.48 | 2.40 |
| 69.32% | 62.41% | |
| EBITDA Margin | 5.76% | 13.78% |
| 404.75% | 139.12% | |
| Net Margin | 8.54% | 6.38% |
| 416.08% | 25.26% |
16 Analysts have issued a sales forecast Hims & Hers Health Inc. 2025 . The average Hims & Hers Health Inc. sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an Hims & Hers Health Inc. EBITDA forecast 2025. The average Hims & Hers Health Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Hims & Hers Health Inc. Analysts have issued a net profit forecast 2025. The average Hims & Hers Health Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.53 | 0.68 |
| 581.82% | 28.30% | |
| P/E | 72.18 | |
| EV/Sales | 4.48 |
15 Analysts have issued a Hims & Hers Health Inc. forecast for earnings per share. The average Hims & Hers Health Inc. EPS is
This results in the following potential growth metrics and future valuations:
Hims & Hers Health Inc....
Current Hims & Hers Health Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jun 11 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
| Needham |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jun 11 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jun 04 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Apr 29 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
